Review tally, page-983

Then things look pretty dire. raised approx 4 mill. 1.5 mill in RD coming in. lets be generous 6 mill in total. Last quarter they lost 1.8 million. It is tracking as this quarter is equally poor. So of that six million they have 4 left. Jan quarter they'll be done further 2 mill (this is without any increase in production) and obviously no revenue increase.
The Gen 4 still hasn't achieved FDA approval and while not as an onerous task as the last model, it still needs to be ticked off before any manufacturing can occur. In turn, Nuheara wouldn't have ordered manufacturing components yet. They would need final FDA approval to ensure the components are right to go or if they need changes.
That then means, before any production is completed, the following still needs to occur; FDA approval, Components Ordered, Manufacturing lines adjusted, Trial Runs and approval for mass production runs, and shipping. For the Pro the announced approval is 31/10/22 and then "Mass" Production and Shipping 16/02. So from the announcement of FDA approval, you are still looking at a full quarter before they are in stores.
So by the time gen 4 is ready they are down to under 2 mill and need to raise again.
It is like dejavu. This was the exact same cycle they go through each time. We used to hear all about the one store per month sale but nothing now and we keep hearing about OEM but there is none or if there is it is so far away they'll have to raise.
We have just been through the biggest weekend of sales in the USA and Justin owes it to shareholders to disclose what the sales were.